22.63
2.31%
+0.51
Handel nachbörslich:
22.63
Atricure Inc Aktie (ATRC) Neueste Nachrichten
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 6.9% in April - MarketBeat
MarketBeat
AtriCure (ATRC): Moving Average Crossover Alert - Yahoo News UK
Yahoo News UK
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference - Business Wire
Business Wire
AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Singapore News
Yahoo Singapore News
AtriCure Enhances Governance and Expands Stock Plan - TipRanks.com - TipRanks
TipRanks
AtriCure (ATRC) Looks Good: Stock Adds 5.1% in Session - Yahoo Movies UK
Yahoo Movies UK
AtriCure (ATRC) Looks Good: Stock Adds 5.1% in Session - Yahoo New Zealand News
Yahoo New Zealand News
AtriCure (ATRC) Looks Good: Stock Adds 5.1% in Session - Yahoo Singapore News
Yahoo Singapore News
TimesSquare Capital Management LLC Purchases 71,275 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
MarketBeat
AtriCure (NASDAQ:ATRC) lifts 9.3% this week, taking five-year gains to 96% - Yahoo Movies UK
Yahoo Movies UK
Global Ablation Devices Market to grow at a CAGR of 11.65% by 2030, Evaluates DelveInsight - openPR
openPR
Needham & Company LLC Lowers AtriCure (NASDAQ:ATRC) Price Target to $40.00 - Defense World
Defense World
Canaccord Genuity Group Trims AtriCure (NASDAQ:ATRC) Target Price to $49.00 - Defense World
Defense World
AtriCure (NASDAQ:ATRC) Given New $34.00 Price Target at JPMorgan Chase & Co. - Defense World
Defense World
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Movies UK
Yahoo Movies UK
AtriCure (NASDAQ:ATRC) Stock Price Up 6.7% - MarketBeat
MarketBeat
Justin J. Noznesky Sells 1500 Shares of AtriCure, Inc. (NASDAQ:ATRC) Stock - Defense World
Defense World
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Defense World
AtriCure executive sells shares worth over $36,000 - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
Justin J. Noznesky Sells 1,500 Shares of AtriCure, Inc. (NASDAQ:ATRC) Stock - MarketBeat
MarketBeat
AtriCure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Yahoo Finance
AtriCure executive sells shares worth over $36000 - Investing.com India
Investing.com India
AtriCure shares target cut $7, maintains Buy rating - Investing.com India
Investing.com India
Canaccord Genuity cuts AtriCure shares target despite strong Q1 - Investing.com India
Investing.com India
AtriCure shares target cut by $6, maintains buy rating - Investing.com India
Investing.com India
New York State Common Retirement Fund Buys 30280 Shares of AtriCure, Inc. (NASDAQ:ATRC) - Defense World
Defense World
AtriCure shares target cut $7, maintains Buy rating By Investing.com - Investing.com UK
Investing.com UK
Canaccord Genuity cuts AtriCure shares target despite strong Q1 - Investing.com
Investing.com
Cracking The Code: Understanding Analyst Reviews For AtriCure
Benzinga
Earnings call: AtriCure reports robust Q1 2024 growth, reaffirms guidance - Investing.com
Investing.com
AtriCure shares target cut by $6, maintains buy rating - Investing.com UK
Investing.com UK
AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Innovations ... - GuruFocus.com
GuruFocus.com
AtriCure (NASDAQ:ATRC) Given New $49.00 Price Target at Canaccord Genuity Group - MarketBeat
MarketBeat
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Canada Finance
Yahoo Canada Finance
AtriCure Reports First Quarter 2024 Financial Results - Business Wire
Business Wire
AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses - Yahoo Finance Australia
Yahoo Finance Australia
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference - Business Wire
Business Wire
AtriCure (NASDAQ:ATRC) Upgraded by Oppenheimer to Outperform - Defense World
Defense World
Objective long/short (ATRC) Report - Stock Traders Daily
Stock Traders Daily
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
Zacks Investment Research
First Week of June 21st Options Trading For AtriCure (ATRC) - Nasdaq
Nasdaq
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management - Yahoo Finance
Yahoo Finance
Key Takeaways From AtriCure Analyst Ratings
Benzinga
Key Takeaways From AtriCure Analyst Ratings - AtriCure (NASDAQ:ATRC) - Benzinga
Benzinga
Revolutionizing Atrial Fibrillation Treatment: The Robotic Convergent Plus Procedure - Cureus
Cureus
Positive Sentiment Still Eludes AtriCure, Inc. (NASDAQ:ATRC) Following 29% Share Price Slump - Simply Wall St
Simply Wall St
AtriCure is top co-op employer for UC biomedical engineering students - University of Cincinnati
University of Cincinnati
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference - Business Wire
Business Wire
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug - Yahoo Finance
Yahoo Finance
Kapitalisierung:
|
Volumen (24h):